MediGene progresses on two fronts
13 December 2011
Eleanor Malone
Please Login to read the full article.
13 December 2011
Eleanor Malone
eleanor.malone@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
- Failed German price negotiations likely to lead to heavy pan-EU discounts
- NICE still down on overall survival benefit of Roche's Herceptin and GSK's Tyverb following appeal
- Nycomed to co-market Orion's Easyhaler products in Europe and MENA region
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
